Top compounds associated with response to LAMA5


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib gCSI pan-cancer AAC 0.41 5e-09
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.22 6e-08
mRNA Erlotinib CCLE pan-cancer AAC 0.32 7e-08
mRNA GSK461364 CTRPv2 pan-cancer AAC -0.19 2e-07
mRNA lapatinib CCLE pan-cancer AAC 0.28 8e-07
mRNA Erlotinib GDSC1000 pan-cancer AAC 0.28 1e-06
mRNA KX2-391 CTRPv2 pan-cancer AAC -0.18 2e-06
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.18 2e-06
mRNA BI-2536 CTRPv2 pan-cancer AAC -0.17 2e-06
mRNA lapatinib gCSI pan-cancer AAC 0.32 2e-06
Download CSV